Generic Name: rolapitant (roe LA pi tant)
Brand Names: Varubi
What is Varubi?
Varubi is used together with other medicines to prevent nausea and vomiting caused by cancer chemotherapy.
Varubi may also be used for purposes not listed in this medication guide.
Varubi can cause a rapid and severe allergic reaction. Tell your doctor if you have a history of allergies to any food or medicines.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
You should not use Varubi if you are allergic to rolapitant. This medicine can cause a rapid and severe allergic reaction. Tell your doctor if you have a history of allergies to any food or medicine.
Some medicines can cause unwanted or dangerous effects when used with Varubi. Your doctor may need to change your treatment plan if you use any of the following drugs:
To make sure this medicine is safe for you, tell your doctor if you have:
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.
This medicine may affect fertility (your ability to have children) for a short time. Talk to your doctor if you have concerns about this.
It is not known whether rolapitant passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Varubi is not approved for use by anyone younger than 18 years old.
How should I use Varubi?
Take Varubi exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Varubi is usually given on Day 1 of your chemotherapy treatment, within 2 hours before the start of chemotherapy. Follow your doctor's instructions.
This medicine is given either as a tablet taken by mouth, or as an injection infused into a vein through an IV. A healthcare provider will give you the injection.
You may take the tablets with or without food.
You should not take tablets more than once every 14 days.
Varubi injection must be given slowly over at least 30 minutes.
You will be given other medication to prevent nausea or vomiting while you are taking this medicine. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice.
Store the tablets at room temperature away from moisture and heat.
Varubi dosing information
Usual Adult Dose for Nausea/Vomiting -- Chemotherapy Induced:
180 mg orally approximately 1 to 2 hours prior to initiation of each chemotherapy cycle.
Comments: Dexamethasone and a 5-HT3 receptor antagonist should be administered concurrently with rolapitant. Consult manufacturer product information for appropriate dosing information for these drugs.
Use: In combination with other antiemetic agents for prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
See also: Dosage Information (in more detail)
What happens if I miss a dose?
The timing of your dose is important for this medicine to be effective. Call your doctor if you forget to take the tablets or you do not receive the injection within 2 hours before your chemotherapy starts.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid after using Varubi?
For at least 1 month after you use Varubi, avoid using any cough or cold medicine that contains dextromethorphan. Talk to your doctor about how to best treat a cough due to the common cold.
Varubi side effects
Get emergency medical help if you have signs of an allergic reaction to Varubi: hives, flushing (warmth, redness, or tingly feeling); feeling light-headed; wheezing, chest pain, difficult breathing, back pain, stomach pain, vomiting swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
pain or burning when you urinate;
low red blood cells (anemia) - pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or
low white blood cell counts - fever, swollen gums, painful mouth sores, skin sores, cold or flu symptoms, cough, trouble breathing.
Common Varubi side effects may include:
indigestion, stomach pain, loss of appetite; or
low blood cell counts.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
What other drugs will affect Varubi?
Other drugs may interact with rolapitant, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your healthcare providers about your current medicines and any medicine you start or stop using. For at least 28 days after you use this medicine, it could affect other medicines you are using.
More about Varubi (rolapitant)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: NK1 receptor antagonists
- Varubi (Rolapitant Injection)
- Varubi (Rolapitant Tablets)
- Varubi (Advanced Reading)
- Varubi Intravenous (Advanced Reading)
Related treatment guides
Where can I get more information?
- Your pharmacist can provide more information about Varubi.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Varubi only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2018 Cerner Multum, Inc. Version: 4.01.
Date modified: February 28, 2018
Last reviewed: January 18, 2018